| Gene symbol | TNFSF13B | Synonyms | BAFF, BLYS, CD257, DTL, TALL-1, TALL1, THANK, TNFSF20, TNLG7A, ZTNF4 | Type of gene | protein-coding | |
| Chromosome | 13 | Map location | 13q33.3 | dbXrefs | Entrez:10673 MIM:603969 HGNC:HGNC:11929 Ensembl:ENSG00000102524 AllianceGenome:HGNC:11929 | |
| Description | TNF superfamily member 13b | |||||
| GTO ID | GTC3825 |
| Trial ID | NCT06340750 |
| Disease | Systemic Lupus Erythematosus |
| Altered gene | TNFSF13B |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LMY-920 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Phase I Study of BAFF CAR-T Cells (LMY-920) for Treatment of Systemic Lupus Erythematosus |
| Year | 2024 |
| Country | United States |
| Company sponsor | Luminary Therapeutics |
| Other ID(s) | LMY-920-003 |
| Cohort 1 | |||||||||
|
|||||||||